Edition:
India

Varian Medical Systems Inc (VAR.N)

VAR.N on New York Stock Exchange

126.13USD
18 Apr 2018
Change (% chg)

$3.08 (+2.50%)
Prev Close
$123.05
Open
$123.60
Day's High
$126.58
Day's Low
$123.40
Volume
194,746
Avg. Vol
197,328
52-wk High
$130.28
52-wk Low
$87.61

Latest Key Developments (Source: Significant Developments)

Varian Medical Systems Replaced $600 Mln Revolving Credit Facility With Revolving Credit Facility, Terminated Credit Agreement Entered On Sept 1
Thursday, 5 Apr 2018 

April 4 (Reuters) - Varian Medical Systems Inc ::REPLACED $600 MILLION REVOLVING CREDIT FACILITY WITH REVOLVING CREDIT FACILITY, TERMINATED CREDIT AGREEMENT ENTERED ON SEPT 1, 2017.YEAR REVOLVING CREDIT FACILITY OF UP TO $1.8 BILLION​.VARIAN MEDICAL SYSTEMS SAYS ENTERED INTO A REVOLVING CREDIT AGREEMENT - SEC FILING.FACILITY FOR ISSUANCE OF LETTERS OF CREDIT AND PERMITS SWING LINE LOANS OF UP TO $25 MILLION​.  Full Article

Sirtex Medical Updates On FIRB Approval Regarding Acquisition Of Co By Varian Medical Systems
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Sirtex Medical Ltd ::‍ANNOUNCES FIRB HAS DECIDED THAT COMMONWEALTH OF AUSTRALIA HAS NO OBJECTION TO VARIAN MEDICAL SYSTEMS TO ACQUIRE SIRTEX​.  Full Article

Sirtex Medical Receives Formal Notification Regarding Acquisition Of Co
Wednesday, 14 Mar 2018 

March 14 (Reuters) - Sirtex Medical Ltd ::ANNOUNCES FORMAL NOTIFICATION FROM U.S. FEDERAL TRADE COMMISSION & GERMAN FEDERAL CARTEL OFFICE ON PROPOSED ACQUISITION OF CO.U.S. FTC GRANTED EARLY TERMINATION OF WAITING PERIOD UNDER CLAYTON ACT & PREMERGER NOTIFICATION RULES WITH RESPECT TO SCHEME.GERMAN FCO CONFIRMED PROPOSED SCHEME DOES NOT FULFIL CONDITIONS FOR PROHIBITION PURSUANT TO ACT AGAINST RESTRAINTS OF COMPETITION.DRAFT SCHEME BOOKLET FOR SCHEME TO SELL CO TO VARIAN MEDICAL SYSTEMS, INC LODGED WITH ASIC ON MARCH 9.  Full Article

Varian Q1 Loss Per Share $1.22 From Continuing Operations
Thursday, 25 Jan 2018 

Jan 24 (Reuters) - Varian Medical Systems Inc ::VARIAN REPORTS RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2018.Q1 GAAP LOSS PER SHARE $1.22 FROM CONTINUING OPERATIONS.Q1 REVENUE $679 MILLION VERSUS I/B/E/S VIEW $640.2 MILLION.Q1 EARNINGS PER SHARE VIEW $0.98 -- THOMSON REUTERS I/B/E/S.Q1 NON-GAAP EARNINGS PER SHARE $1.06 FROM CONTINUING OPERATIONS.SEES FY 2018 REVENUE GROWTH RANGE OF 4 PERCENT TO 7 PERCENT.FY2018 REVENUE VIEW $2.77 BILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $4.24 -- THOMSON REUTERS I/B/E/S.VARIAN MEDICAL SYSTEMS - SEES FY 2018 NON-GAAP EARNINGS PER DILUTED SHARE RANGE OF $4.24 TO $4.36.  Full Article

Varian Medical Systems Sees FY 2018 Adjusted EPS Of $4.05 To $4.17 From Continuing Operations
Friday, 12 Jan 2018 

Jan 11 (Reuters) - Varian Medical Systems Inc ::SAYS NOW SEES FY 2018 ADJUSTED EARNINGS PER SHARE OF $4.05 TO $4.17 FROM CONTINUING OPERATIONS - SEC FILING.- SEES FY 2018 REVENUE GROWTH BETWEEN 3 PERCENT TO 5 PERCENT.FY2018 EARNINGS PER SHARE VIEW $4.30, REVENUE VIEW $2.77 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Varian Medical Systems Signed MoU With Ping An Health Technology
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Varian Medical Systems Inc ::VARIAN MEDICAL SYSTEMS - SIGNED MOU WITH PING AN HEALTH TECHNOLOGY TO EXPLORE STRATEGIC PARTNERSHIP FOR EXPANDING ACCESS TO CANCER CARE IN CHINA.  Full Article

Varian Halcyon Treatment System Receives Taiwan FDA Approval
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Varian Medical Systems Inc ::VARIAN HALCYON TREATMENT SYSTEM RECEIVES TAIWAN FDA APPROVAL.VARIAN MEDICAL SYSTEMS INC - ANNOUNCED CO'S HALCYON SYSTEM HAS RECEIVED TAIWAN FDA APPROVAL.  Full Article

Varian Medical Systems Says CEO's FY 2017 Total Compensation Was $8.3 Mln
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Varian Medical Systems Inc ::VARIAN MEDICAL SYSTEMS SAYS CEO DOW WILSON'S FY 2017 TOTAL COMPENSATION WAS $8.3 MILLION VERSUS $8.6 MILLION IN 2016 - SEC FILING.  Full Article

Varian Halcyon Treatment System Receives ANVISA Registration In Brazil
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Varian Medical Systems Inc ::VARIAN HALCYON TREATMENT SYSTEM RECEIVES ANVISA REGISTRATION IN BRAZIL.VARIAN MEDICAL SYSTEMS INC- REGISTRATION ALLOWS VARIAN TO MARKET HALCYON SYSTEM IN BRAZIL.  Full Article

Varian's Halcyon system receives Shonin approval to market in Japan
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Varian Medical Systems Inc -:Varian Halcyon treatment system receives Shonin approval.Varian Medical Systems Inc - ‍received Shonin approval from Japanese Ministry Of Health, Labor And Welfare to market in Japan the Varian Halcyon system​.  Full Article

BRIEF-Varian Medical Systems Replaced $600 Mln Revolving Credit Facility With Revolving Credit Facility, Terminated Credit Agreement Entered On Sept 1

* REPLACED $600 MILLION REVOLVING CREDIT FACILITY WITH REVOLVING CREDIT FACILITY, TERMINATED CREDIT AGREEMENT ENTERED ON SEPT 1, 2017